Search

Your search keyword '"Garg, Scot"' showing total 930 results

Search Constraints

Start Over You searched for: Author "Garg, Scot" Remove constraint Author: "Garg, Scot"
930 results on '"Garg, Scot"'

Search Results

1. Murray law-based quantitative flow ratio to assess left main bifurcation stenosis: selecting the angiographic projection matters

2. Computed tomographic angiography in coronary artery disease.

3. CCTA-based CABG SYNTAX Score: a tool to evaluate completeness of coronary segment revascularization after bypass surgery

5. Treatment recommendation based on SYNTAX score 2020 derived from coronary computed tomography angiography and invasive coronary angiography

6. Impact of repeat revascularization within 5 years on 10-year mortality after percutaneous or surgical revascularization

7. LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial

9. Short-Term Outcomes of ACURATE neo2

10. Geographic disparity of pathophysiological coronary artery disease characteristics: Insights from ASET trials

12. Coronary computed tomography angiography-based SYNTAX score for comprehensive assessment of advanced coronary artery disease

14. Frequency of periprocedural myocardial injury and infarction stratified by cardiac troponin I and cardiac troponin T

16. A Prospective Randomized Trial Comparing Sirolimus-Coated Balloon With Paclitaxel-Coated Balloon in De Novo Small Vessels

17. The ability of computed tomography angiography to predict 5-year mortality in the SYNTAX III REVOLUTION trial

22. A systematic screening and heart team approach contributes to unravel novel risk factors in revascularisation candidates of complex coronary artery disease: a machine learning approach

23. LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial

24. Quantitative coronary computed tomography assessment for differentiating between total occlusions and severe stenoses

26. Geographic disparity in 10-year mortality after coronary artery revascularization in the SYNTAXES trial

27. Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations

30. Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design

31. Ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the SYNTAX Extended Survival study

34. A prospective multicenter validation study for a novel angiography-derived physiological assessment software: Rationale and design of the radiographic imaging validation and evaluation for Angio-iFR (ReVEAL iFR) study

37. 10-Year Follow-Up After Revascularization in Elderly Patients With Complex Coronary Artery Disease

38. Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis

39. Influence of Bleeding Risk on Outcomes of Radial and Femoral Access for Percutaneous Coronary Intervention: An Analysis From the GLOBAL LEADERS Trial

40. Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS)

41. Routine Pressure Wire Assessment Versus Conventional Angiography in the Management of Patients With Coronary Artery Disease: The RIPCORD 2 Trial

45. The impact of pre-procedure heart rate on adverse clinical outcomes in patients undergoing percutaneous coronary intervention: Results from a 2-year follow-up of the GLOBAL LEADERS trial

46. Association of Pulse Pressure With Clinical Outcomes in Patients Under Different Antiplatelet Strategies After Percutaneous Coronary Intervention: Analysis of GLOBAL LEADERS

47. DAPT Score and the Impact of Ticagrelor Monotherapy During the Second Year After PCI

48. Association of diabetes with outcomes in patients undergoing contemporary percutaneous coronary intervention: Pre-specified subgroup analysis from the randomized GLOBAL LEADERS study

49. Prasugrel Monotherapy After Percutaneous Coronary Intervention for Chronic Coronary Syndrome

50. Feasibility and accuracy of real-time 3D-holographic graft length measurement

Catalog

Books, media, physical & digital resources